THERRY PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
THERRY PHARMA
Largest movements
- Tangible fixed assets +€11,743
up €11,743 (+984.4%), from €1,193 to €12,936
of which Furniture and vehicles: +€6,284
- Intangible fixed assets -€4,529
down €4,529 (-20.0%), from €22,646 to €18,117
- Receivables within one year +€3,743
up €3,743 (+6.4%), from €58,429 to €62,172
of which Trade receivables: +€7,548
- Stocks and contracts -€3,551
down €3,551 (-5.8%), from €61,368 to €57,818
- Cash +€2,421
up €2,421 (+8.0%), from €30,242 to €32,663
mainly Other debts (+€11,069) and Net result for the year (+€7,144)
- Other debts +€11,069
up €11,069 (+12.3%), from €90,212 to €101,281
- Profit (loss) carried forward +€7,144
up €7,144 (+22.8%), from -€31,332 to -€24,188
- Debts after one year -€5,517
down €5,517 (-19.7%), from €28,052 to €22,535
- Trade debts -€4,879
down €4,879 (-10.8%), from €45,240 to €40,361
- Gross operating margin -€12,767
down €12,767 (-9.3%), from €137,328 to €124,561
- Staff costs +€12,525
up €12,525 (+14.8%), from €84,832 to €97,358
- Taxes -€4,543
down €4,543 (-45.4%), from €10,012 to €5,469
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €177,635 | €185,837 | +€8,201 | +4.6% |
| Fixed assets | 21/28 | €23,839 | €31,053 | +€7,214 | +30.3% |
| Intangible fixed assets | 21 | €22,646 | €18,117 | -€4,529 | -20.0% |
| Tangible fixed assets | 22/27 | €1,193 | €12,936 | +€11,743 | +984.4% |
| Plant, machinery and equipment | 23 | €1,193 | €6,651 | +€5,458 | +457.6% |
| Furniture and vehicles | 24 | €0 | €6,284 | +€6,284 | |
| Current assets | 29/58 | €153,796 | €154,784 | +€988 | +0.6% |
| Stocks and contracts in progress | 3 | €61,368 | €57,818 | -€3,551 | -5.8% |
| Stocks | 30/36 | €61,368 | €57,818 | -€3,551 | -5.8% |
| Amounts receivable within one year | 40/41 | €58,429 | €62,172 | +€3,743 | +6.4% |
| Trade receivables | 40 | €54,087 | €61,635 | +€7,548 | +14.0% |
| Other amounts receivable | 41 | €4,342 | €538 | -€3,805 | -87.6% |
| Cash at bank and in hand | 54/58 | €30,242 | €32,663 | +€2,421 | +8.0% |
| Deferred charges and accrued income | 490/1 | €3,756 | €2,131 | -€1,626 | -43.3% |
| Total equity and liabilities | 10/49 | €177,635 | €185,837 | +€8,201 | +4.6% |
| Equity | 10/15 | -€9,332 | -€2,188 | +€7,144 | +76.6% |
| Contributions | 10/11 | €22,000 | €22,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€31,332 | -€24,188 | +€7,144 | +22.8% |
| Amounts payable | 17/49 | €186,967 | €188,025 | +€1,058 | +0.6% |
| Amounts payable after more than one year | 17 | €28,052 | €22,535 | -€5,517 | -19.7% |
| Financial debts | 170/4 | €28,052 | €22,535 | -€5,517 | -19.7% |
| Amounts payable within one year | 42/48 | €151,072 | €159,114 | +€8,041 | +5.3% |
| Current portion of amounts payable after more than one year | 42 | €5,270 | €5,517 | +€247 | +4.7% |
| Trade debts | 44 | €45,240 | €40,361 | -€4,879 | -10.8% |
| Suppliers | 440/4 | €45,240 | €40,361 | -€4,879 | -10.8% |
| Taxes, remuneration and social security | 45 | €10,350 | €11,955 | +€1,605 | +15.5% |
| Taxes | 450/3 | €0 | - | = | |
| Remuneration and social security | 454/9 | €10,350 | €11,955 | +€1,605 | +15.5% |
| Other amounts payable | 47/48 | €90,212 | €101,281 | +€11,069 | +12.3% |
| Accrued charges and deferred income | 492/3 | €7,843 | €6,377 | -€1,467 | -18.7% |
| Remuneration, social security and pensions | 62 | €84,832 | €97,358 | +€12,525 | +14.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,729 | €5,868 | +€140 | +2.4% |
| Other operating charges | 640/8 | €1,673 | €1,717 | +€44 | +2.6% |
| Gross operating margin | 9900 | €137,328 | €124,561 | -€12,767 | -9.3% |
| Operating profit (loss) | 9901 | €45,094 | €19,618 | -€25,476 | -56.5% |
| Financial income | 75/76B | €1,442 | €1,115 | -€327 | -22.7% |
| Recurring financial income | 75 | €1,442 | €1,115 | -€327 | -22.7% |
| Financial charges | 65/66B | €9,135 | €8,120 | -€1,015 | -11.1% |
| Recurring financial charges | 65 | €9,135 | €8,120 | -€1,015 | -11.1% |
| Profit (loss) for the period before taxes | 9903 | €37,401 | €12,613 | -€24,788 | -66.3% |
| Income taxes | 67/77 | €10,012 | €5,469 | -€4,543 | -45.4% |
| Profit (loss) for the period | 9904 | €27,389 | €7,144 | -€20,245 | -73.9% |
| Profit (loss) for the period to be appropriated | 9905 | €27,389 | €7,144 | -€20,245 | -73.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.